Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Four Mycophenolate Mofetil Formulations in Healthy Subjects
NCT02981290Phase 1Completed
- Sponsor
- Roche
- Start
- Jul 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mycophenolate mofetil in organ transplant rejection (4 arms), sponsored by Roche. Primary endpoints: Area Under the Curve From Time Zero to Extrapolated Infinite Time of Mycophenolic Acid at Day 1, Area Under the Curve From Time Zero to Last Quantifiable Concentration of Mycophenolic Acid at Day 1 and 5 more. Started Jul 2008; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
organ transplant rejection
Beyond the preview
Go deeper on NCT02981290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02981290.